Chronic increases in blood flow upregulate endothelin-B receptors in arterial smooth muscle

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 270, Issue 1 39-1, 1996, Pages

  Barber, Dustan A ^a   Michener, Sandra R ^a   Ziesmer, Steven C ^a   Miller, Virginia M ^a  

^a MAYO CLINIC   (United States)

Author keywords

arteriovenous fistula; endothelin B antibody; remodeling; sarafotoxin S6c

Indexed keywords

ENDOTHELIN B RECEPTOR; RECEPTOR SUBTYPE; SARAFOTOXIN S6C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIOVENOUS FISTULA; ARTERY MUSCLE; ARTICLE; BINDING SITE; BLOOD FLOW VELOCITY; CONTROLLED STUDY; DOG; HEART VENTRICLE REMODELING; NONHUMAN; OXYGEN TENSION; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR UPREGULATION;

EID: 0030062809     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.270.1.h65     Document Type: Article

References (25)

1. Arai, H., S. Hori, I. Aramori, H. Ohkubo, and S. Nakanishi. Cloning and expression of cDNA encoding an endothelin receptor. Nature Lond. 348: 730-732, 1990.
2. Chang, H., G.-J. Wu, S.-M. Wang, and C.-R. Hung. Plasma endothelin levels and surgically correctable pulmonary hypertension Ann. Thorac Surg. 55: 450-458, 1993.
3. Dubin, D., R. E. Pratt, J. P. Cooke, and V. J. Dzau. Endothelin, a potent vasoconstrictor, is a vascular smooth muscle mitogen. J. Vasc. Med. Biol. 1: 150-154, 1989.
4. Eguchi, S., Y. Hirata, M. Ihara, M. Yano, and F. Marumo. A novel ETA antagonist (BQ-123) inhibits endothelin-1-induced phosphoinositide breakdown and DNA synthesis in rat vascular smooth muscle cells. FEBS Lett. 302: 243-246, 1992.
5. Eguchi, S., Y. Hirata, T. Imai, K. Kanno, and F. Marumo. Phenotypic changes of endothelin receptor subtype in cultured rat vascular smooth muscle cells. Endocrinology 134: 222-228, 1994.
6. Heida, H. S., and C. E. Gomez-Sanchez. Hypoxia increases endothelin release in bovine endothelial cells in culture, but epinephrine, norepinephrine, serotonin, histamine and angiotensin II do not. Life Sci. 47: 247-251, 1990.
7. Hirata, Y., Y. Takagi, Y. Fukuda, and F. Marumo. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Arteriosclerosis 78: 225-228, 1989.
8. Langille, B. L., and F. O'Donnell. Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. Science Wash. DC 231: 405-407, 1986.
9. Masaki, T., J. R. Vane, and P. M. Vanhoutte. International Union of Pharmacology nomenclature of endothelin receptors. Pharmacol. Rev. 46: 137-142, 1994.
10. Masuda, H., H. Bassiouny, S. Glagov, and C. K. Zarins. Artery wall restructuring in response to increased flow. Surg. Forum 40: 285-286, 1989.
11. Miller, V. M. Selective production of endothelium-derived nitric oxide in canine femoral veins. Am. J. Physiol. 261 (Heart Circ. Physiol. 30): H677-H682, 1991.
12. Miller, V. M., L. L. Aarhus, and P. M. Vanhoutte. Modulation of endothelium-dependent responses by chronic alterations of blood flow. Am. J. Physiol. 251 (Heart Circ. Physiol. 20): H520-H527, 1986.
13. Miller, V. M., and J. C. Burnett, Jr. Modulation of nitric oxide and endothelin by chronic increases in blood flow in canine femoral arteries. Am. J. Physiol. 263 (Heart Circ. Physiol. 32): H103-H108, 1992.
14. Miller, V. M., and J. Gutkowska. Modulation of arterial endothelin-1 receptors following chronic increases in blood flow. J. Cardiovasc. Pharmacol. 20. Suppl. 12: S15-S18, 1992.
15. Miller, V. M., K. Komori, J. C. Burnett, Jr., and P. M. Vanhoutte. Differential sensitivity to endothelin in canine arteries and veins. Am. J. Physiol. 257 (Heart Circ. Physiol. 26): H1127-H1131, 1989.
16. Miller, V. M., and S. R. Michener. Modulation of contractions to and receptors for endothelins in canine veins. Am. J. Physiol. 268 (Heart Circ. Physiol. 37): H345-H350, 1995.
17. B-like receptors. Biochem. Biophys. Res. Commun. 184: 100-106, 1992.
18. Munson, P. J., and D. Rodbard. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107: 220-239, 1980.
19. Sakurai, T., M. Yanagisawa, Y. Takuwa, H. Miyazaki, S. Kimura, K. Goto, and T. Masaki. Cloning of cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature Lond. 348: 732-735, 1990.
20. Sharefkin, J. B., S. L. Diamond, S. G. Eskin, L. V. McIntire, and C. W. Dieffenbach. Fluid flow decreases preproendothelin mRNA levels and suppresses endothelin-1 peptide release in cultured human endothelial cells. J. Vasc. Surg. 14: 1-9, 1991.
21. Sumner, M. J., T. R. Cannon, J. W. Mundin, D. G. White, and I. S. Watts. Endothelin ETA and ETg receptors mediate vascular smooth muscle contraction. Br. J. Pharmacol. 107: 858-860, 1992.
22. Teerlink, J. R., V. Breu, U. Sprecher, M. Clozel, and J. P. Clozel. Potent vasoconstriction mediated by endothelin ETB receptors in canine coronary arteries. Circ. Res. 74: 105-114, 1994.
23. B receptors mediate vascular smooth-muscle contraction. J. Cardiovasc. Pharmacol. 22, Suppl. 8: S144-S148, 1993.
24. Williams, D. L., Jr., K. L. Jones, D. J. Pettibone, E. V. Lis, and B. V. Clineschmidt. Sarafotoxin S6c: an agonist which distinguishes between endothelin receptor subtypes. Biochem. Biophys. Res. Commun. 175: 556-561, 1991.
25. Zarins, C. K., M. A. Zatina, D. P. Giddens, D. N. Ku, and S. Glagov. Shear stress regulation of artery lumen diameter in experimental atherogenesis. J. Vasc. Surg. 5: 413-420, 1987.